Related references
Note: Only part of the references are listed.Nanotheranostics for personalized medicine
Simona Mura et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Anchored Proteinase-Targetable Optomagnetic Nanoprobes for Molecular Imaging of Invasive Cancer Cells
Joseph Park et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Tumor-targeted drug delivery using MR-contrasted docetaxel - Carboxymethylcellulose nanoparticles
Mark J. Ernsting et al.
BIOMATERIALS (2012)
Innovative ligand-assisted synthesis of NIR-activated iron oxide for cancer theranostics
Mei-Yi Liao et al.
CHEMICAL COMMUNICATIONS (2012)
Image guided therapy: The advent of theranostic agents
Enzo Terreno et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Lammers et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine
Wafa' T. Al-Jamal et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Target-Cancer-Cell-Specific Activatable Fluorescence Imaging Probes: Rational Design and in Vivo Applications
Hisataka Kobayashi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Theranostic Nanoparticles Engineered for Clinic and Pharmaceutics
Xiaowei Ma et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Molecular Imaging with Theranostic Nanoparticles
Jesse V. Jokerst et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Theranostic Nanomedicine
Twan Lammers et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Supramolecular Nanodevices: From Design Validation to Theranostic Nanomedicine
Horacio Cabral et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Surface Engineering of Iron Oxide Nanoparticies for Targeted Cancer Therapy
Forrest M. Kievit et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery Carriers
Mary E. Caldorera-Moore et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Theranostic Magnetic Nanoparticles
Dongwon Yoo et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms
Alicia Fernandez-Fernandez et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2011)
Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases
Jennifer M. Atkinson et al.
CANCER RESEARCH (2010)
Macromolecules, Dendrimers, and Nanomaterials in Magnetic Resonance Imaging: The Interplay between Size, Function, and Pharmacokinetics
Aaron Joseph L. Villaraza et al.
CHEMICAL REVIEWS (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
Emilia S. Olson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival
Quyen T. Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Engineering Nanocomposite Materials for Cancer Therapy
Caterina Minelli et al.
SMALL (2010)
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Laetitia Devy et al.
CANCER RESEARCH (2009)
Physicochemical properties of ferumoxytol, a new intravenous iron preparation
V. S. Balakrishnan et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies
Chryso Kanthou et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Tumour endoproteases: the cutting edge of cancer drug delivery?
J. M. Atkinson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo
Constantino Carlos Reyes-Aldasoro et al.
MICROCIRCULATION (2008)
Vascular disrupting agents in clinical development
P. Hinnen et al.
BRITISH JOURNAL OF CANCER (2007)
The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiograpgy in central nervous system malignancy:: A pilot study
Edward A. Neuwelt et al.
NEUROSURGERY (2007)
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models
Lyuba Varticovski et al.
CLINICAL CANCER RESEARCH (2007)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Pharmacokinetic study of ferumoxytol: A new iron replacement therapy in normal subjects and hemodialysis patients
R Landry et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent
W Li et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2005)
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages
MC Bibby
EUROPEAN JOURNAL OF CANCER (2004)
Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
F Marcucci et al.
DRUG DISCOVERY TODAY (2004)
Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP
F Sabeh et al.
JOURNAL OF CELL BIOLOGY (2004)
Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors
J Ueda et al.
ONCOGENE (2003)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Improvement of MRI probes to allow efficient detection of gene expression
D Högemann et al.
BIOCONJUGATE CHEMISTRY (2000)